Literature DB >> 25644153

Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer.

Alejandro Sanchez1, Matthew F Wszolek1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25644153     DOI： 10.1038/nrurol.2015.12

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

Authors:  Jason A Efstathiou; Daphna Y Spiegel; William U Shipley; Niall M Heney; Donald S Kaufman; Andrzej Niemierko; John J Coen; Rafi Y Skowronski; Jonathan J Paly; Francis J McGovern; Anthony L Zietman
Journal:  Eur Urol       Date:  2011-11-12       Impact factor: 20.096

2.  The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.

Authors:  Paolo Gontero; Marco Oderda; Anja Mehnert; Alberto Gurioli; Francesco Marson; Ilaria Lucca; Michael Rink; Marianne Schmid; Luis A Kluth; Giovanni Pappagallo; Filippo Sogni; Francesco Sanguedolce; Riccardo Schiavina; Giuseppe Martorana; Shahrokh F Shariat; Felix Chun
Journal:  J Urol       Date:  2013-03-29       Impact factor: 7.450

3.  Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study.

Authors:  Stefanie Schmidt; Albert Francés; José Antonio Lorente Garin; Nuria Juanpere; José Lloreta Trull; Xavier Bonfill; María José Martinez-Zapata; Maria Morales Suarez-Varela; Javier de la Cruz; José Ignacio Emparanza; María-José Sánchez; Javier Zamora; José Ignacio Pijoan; Jordi Alonso; Montse Ferrer
Journal:  Urol Oncol       Date:  2014-10-22       Impact factor: 3.498

4.  Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

Authors:  A L Zietman; J Grocela; E Zehr; D S Kaufman; R H Young; A F Althausen; N M Heney; W U Shipley
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

5.  Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors.

Authors:  Anthony L Zietman; Dianne Sacco; Uri Skowronski; Pablo Gomery; Donald S Kaufman; Jack A Clark; James A Talcott; William U Shipley
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

6.  Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study.

Authors:  Chunkit Fung; Chintan Pandya; Elizabeth Guancial; Katia Noyes; Deepak M Sahasrabudhe; Edward M Messing; Supriya G Mohile
Journal:  J Urol       Date:  2014-04-01       Impact factor: 7.450

7.  Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.

Authors:  Christian Weiss; Michael Wittlinger; Dirk G Engehausen; Frens S Krause; Oliver J Ott; Jürgen Dunst; Rolf Sauer; Claus Rödel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-01       Impact factor: 7.038

Review 8.  Management of local recurrences in the irradiated bladder: a systematic review.

Authors:  Nikhil Sapre; Paul Anderson; Farshad Foroudi
Journal:  BJU Int       Date:  2012-12       Impact factor: 5.588

9.  Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.

Authors:  Jane M Blazeby; Emma Hall; Neil K Aaronson; Lisa Lloyd; Rachel Waters; John D Kelly; Peter Fayers
Journal:  Eur Urol       Date:  2014-02-25       Impact factor: 20.096
  9 in total
  5 in total

1.  Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors.

Authors:  Ahrang Jung; Jamie L Crandell; Matthew E Nielsen; Sophia K Smith; Ashley Leak Bryant; Deborah K Mayer
Journal:  Support Care Cancer       Date:  2022-04-18       Impact factor: 3.603

2.  Assessment of Pain, Acceptance of Illness, Adaptation to Life, and Strategies of Coping With the Disease, in Patients With Bladder Cancer.

Authors:  Urszula Religioni; Aleksandra Czerw; Andrzej Deptala
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 3.  The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.

Authors:  Amanda J Edmondson; Jacqueline C Birtwistle; James W F Catto; Maureen Twiddy
Journal:  J Cancer Surviv       Date:  2017-02-17       Impact factor: 4.442

4.  An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and End Results (SEER) study.

Authors:  Yan Zang; Xiao Li; Yifei Cheng; Feng Qi; Ningli Yang
Journal:  Ann Transl Med       Date:  2020-12

5.  Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.

Authors:  Xun Jin; Peilan Zhang; Li Luo; Hao Cheng; Yunzu Li; Ting Du; Bingwen Zou; Maling Gou
Journal:  Int J Nanomedicine       Date:  2016-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.